Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/122051

Título:	Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
Autor/a:	Mesquita, Fernanda Cristina de; Guixé Muntet, Sergi; Fernández Iglesias, Anabel; Maeso Díaz, Raquel; Vila, Sergi; Hide Alférez, Diana; Ortega Ribera, Martí; Rosa López, José Luis; García Pagán, Juan Carlos; Bosch i Genover, Jaume; Oliveira, Jarbas Rodrigues de; Gracia-Sancho, Jorge
Notas:	Hepatic stellate cells (HSC) play a key role in the development of chronic liver disease (CLD). Liraglutide, well-established in type 2 diabetes, showed anti-inflammatory and anti-oxidant properties. We evaluated the effects of liraglutide on HSC phenotype and hepatic microvascular function using diverse pre-clinical models of CLD. Human and rat HSC were in vitro treated with liraglutide, or vehicle, and their phenotype, viability and proliferation were evaluated. In addition, liraglutide or vehicle was administered to rats with CLD. Liver microvascular function, fibrosis, HSC phenotype and sinusoidal endothelial phenotype were determined. Additionally, the effects of liraglutide on HSC phenotype were analysed in human precision-cut liver slices. Liraglutide markedly improved HSC phenotype and diminished cell proliferation. Cirrhotic rats receiving liraglutide exhibited significantly improved liver microvascular function, as evidenced by lower portal pressure, improved intrahepatic vascular resistance, and marked ameliorations in fibrosis, HSC phenotype and endothelial function. The anti-fibrotic effects of liraglutide were confirmed in human liver tissue and, although requiring further investigation, its underlying molecular mechanisms suggested a GLP1-R-independent and NF-κB-Sox9-dependent one. This study demonstrates for the first time that liraglutide improves the liver sinusoidal milieu in pre-clinical models of cirrhosis, encouraging its clinical evaluation in the treatment of chronic liver disease.
Materia(s):	-Cirrosi hepàtica -Malalties del fetge -Hepatic cirrhosis -Liver diseases
Derechos:	cc-by (c) Mesquita, Fernanda Cristina de et al., 2017 http://creativecommons.org/licenses/by/3.0/es
Tipo de documento:	Artículo Artículo - Versión publicada
Editor:	Nature Publishing Group
Compartir:

Mostrar el registro completo del ítem